4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-22-053372
Chief Operating Officer sold 3,125 shares at an average $7.26 ($22,685)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ADAMS R MARK Chief Operating Officer | 2022-10-07 | Sale | −841 | $7.61 | $6,400 | 118,927 | D |
| ADAMS R MARK Chief Operating Officer | 2022-10-10 | Sale | −2,284 | $7.13 | $16,285 | 116,643 | D |
| Open-market sales · 3,125 sh · avg $7.26 · $22,685 | |||||||
Loading xslF345X03/doc4.xml…